↓ Skip to main content

Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials

Overview of attention for article published in Cardiovascular Diabetology, February 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials
Published in
Cardiovascular Diabetology, February 2014
DOI 10.1186/1475-2840-13-33
Pubmed ID
Authors

Nayyar Iqbal, Artist Parker, Robert Frederich, Mark Donovan, Boaz Hirshberg

Abstract

It is important to establish the cardiovascular (CV) safety profile of novel antidiabetic drugs.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 88 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 17%
Researcher 12 13%
Student > Bachelor 10 11%
Other 7 8%
Student > Ph. D. Student 6 7%
Other 22 25%
Unknown 17 19%
Readers by discipline Count As %
Medicine and Dentistry 43 48%
Pharmacology, Toxicology and Pharmaceutical Science 8 9%
Agricultural and Biological Sciences 4 4%
Nursing and Health Professions 3 3%
Computer Science 3 3%
Other 8 9%
Unknown 20 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2014.
All research outputs
#17,285,668
of 25,374,647 outputs
Outputs from Cardiovascular Diabetology
#1,063
of 1,653 outputs
Outputs of similar age
#203,223
of 322,629 outputs
Outputs of similar age from Cardiovascular Diabetology
#17
of 34 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,653 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 322,629 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.